Federated Hermes, Inc. Oramed Pharmaceuticals Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$1.71 - $2.57 $422 - $634	247 Added 202.46%	369 $0
Q3 2023 Nov 13, 2023	BUY	$2.51 - $3.55 $306 - $433	122 New	122 $0
Q1 2023 May 08, 2023	BUY	$1.93 - $13.1 $1,320 - $8,960	684 New	684 $1,000
Q3 2021 Nov 15, 2021	SELL	$12.13 - $23.82 $5,325 - $10,456	-439 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $3,661 - $6,405	439 New	439 $6,000

Q2 2020 Aug 13, 2020	SELL	$2.87 - $4.12 $1,538 - $2,208	-536 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.6 - $5.5 $1,393 - $2,948	536 New	536 $2,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.1M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.